Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Export

@article{citeulike:3689391, abstract = {In 189 opioid-dependent subjects on methadone maintenance treatment in Barcelona (Spain), we assessed the prevalence of co-occurrence substance use and non-substance-use disorders (dual diagnosis) by the Psychiatric Research Interview for Substance and Mental Disorders [PRISM], and the impact on quality of life (HRQoL) by the SF-12 (PCS-12 and MCS-12 scales). Rates of substance and non-substance-use diagnoses were 59\% and 32\%, respectively. Mean scores for PCS-12 and MCS-12 were 44.1+/-10.1 and 39.9+/-11.7, without differences by presence or absence of dual diagnosis. Heroin users on methadone treatment showed a high prevalence of dual diagnosis and a very impaired HRQoL.}, author = {Astals, M. and Domingo-Salvany, A. and Buenaventura, C. C. and Tato, J. and Vazquez, J. M. and Mart\'{\i}n-Santos, R. and Torrens, M.}, citeulike-article-id = {3689391}, citeulike-linkout-0 = {http://dx.doi.org/10.1080/10826080701204813}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/18393080}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=18393080}, doi = {10.1080/10826080701204813}, issn = {1082-6084}, journal = {Substance use \& misuse}, keywords = {dual\_diagnosis, heroin, quality\_of\_life, sf-12, substance\_use}, number = {5}, pages = {612--632}, posted-at = {2008-11-25 18:51:51}, priority = {2}, title = {Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.}, url = {http://dx.doi.org/10.1080/10826080701204813}, volume = {43}, year = {2008} }

TY - JOUR ID - citeulike:3689391 L3 - citeulike-article-id:3689391 N2 - In 189 opioid-dependent subjects on methadone maintenance treatment in Barcelona (Spain), we assessed the prevalence of co-occurrence substance use and non-substance-use disorders (dual diagnosis) by the Psychiatric Research Interview for Substance and Mental Disorders [PRISM], and the impact on quality of life (HRQoL) by the SF-12 (PCS-12 and MCS-12 scales). Rates of substance and non-substance-use diagnoses were 59% and 32%, respectively. Mean scores for PCS-12 and MCS-12 were 44.1+/-10.1 and 39.9+/-11.7, without differences by presence or absence of dual diagnosis. Heroin users on methadone treatment showed a high prevalence of dual diagnosis and a very impaired HRQoL. IS - 5 JF - Substance use & misuse SN - 1082-6084 EP - 632 TI - Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. VL - 43 SP - 612 KW - dual_diagnosis KW - heroin KW - quality_of_life KW - sf-12 KW - substance_use AU - Astals, M AU - Domingo-Salvany, A AU - Buenaventura, CC AU - Tato, J AU - Vazquez, JM AU - Martín-Santos, R AU - Torrens, M PY - 2008/// UR - http://dx.doi.org/10.1080/10826080701204813 ER -